Note: Ingredients listed on restricted chemical lists
EC/CAS
500-038-2/25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
30%
EC/CAS
215-687-4/1344-09-8
Name of the chemical
Silicic acid, sodium salt
Concentration
10%
EC/CAS
201-134-4/78-70-6
Name of the chemical
1,6-Octadien-3-ol, 3,7-dimethyl
Concentration
0.03-0.21%
EC/CAS
203-375-0/106-22-9
Name of the chemical
Citronellol/ (±) 3,7-Dimethyl-6-octen-1-ol
Concentration
0.03-0.15%
EC/CAS
226-394-6/5392-40-5
Name of the chemical
Citral
Concentration
0.003-0.06%
EC/CAS
600-006-9/8008-57-9
Name of the chemical
Citrus aurantium amara and dulcis peel oil (40)
Concentration
0.3-1.5% 3%
General Information
Revision date
2023-07-30
Product name
BIO URINAL BLOCK
Emergency telephone
+61 435 313 535
Icons in SDS
Company Information
company name
CHEMSOLVE PTY LTD
e-mail address of the competent person responsible for the Safety Data Sheet
dhaval@chemsolve.com.au
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H317, H319
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Hazard statements
see SECTION 16 H302: Harmful if swallowed. H317: May cause an allergic skin reaction H319: Causes serious eye irritation.
2.2 Label elements
Labelling
Precautionary statements
P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P280: Wear eye protection/face protection. 1
Response
P301 + P312 IF SWALLOWED Call a POISON CENTER/ doctor, if you feel unwell P330: Rinse mouth. P305 + P351 + P338 IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists Get medical advice/attention
Storage
No special requirement Disposal precautionary statements: P501: Dispose of contents/container to relevant local and national regulations (It is recommended to use incineration method to dispose of waste).
2.3 Other hazards
None ingredients (≥0.1%) meets the criteria for PBT/vPvB in accordance with Annex XIII